183 related articles for article (PubMed ID: 29383871)
1. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study.
Baschin M; Selleng S; Hummel A; Diedrich S; Schroeder HW; Kohlmann T; Westphal A; Greinacher A; Thiele T
J Thromb Haemost; 2018 Apr; 16(4):709-717. PubMed ID: 29383871
[TBL] [Abstract][Full Text] [Related]
2. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
[TBL] [Abstract][Full Text] [Related]
3. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Xia JG; Qu Y; Shen H; Liu XH
Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
[TBL] [Abstract][Full Text] [Related]
4. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
5. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital.
Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N
J Am Coll Surg; 2013 Dec; 217(6):1044-53. PubMed ID: 24051069
[TBL] [Abstract][Full Text] [Related]
6. Non-cardiac surgery in patients with coronary stents: the RECO study.
Albaladejo P; Marret E; Samama CM; Collet JP; Abhay K; Loutrel O; Charbonneau H; Jaber S; Thoret S; Bosson JL; Piriou V
Heart; 2011 Oct; 97(19):1566-72. PubMed ID: 21791513
[TBL] [Abstract][Full Text] [Related]
7. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery.
Stone DH; Goodney PP; Schanzer A; Nolan BW; Adams JE; Powell RJ; Walsh DB; Cronenwett JL;
J Vasc Surg; 2011 Sep; 54(3):779-84. PubMed ID: 21571492
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study.
Thiele T; Sümnig A; Hron G; Müller C; Althaus K; Schroeder HW; Greinacher A
J Thromb Haemost; 2012 May; 10(5):968-71. PubMed ID: 22429740
[No Abstract] [Full Text] [Related]
10. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents.
Kim C; Kim JS; Kim H; Ahn SG; Cho S; Lee OH; Park JK; Shin S; Moon JY; Won H; Suh Y; Cho JR; Cho YH; Oh SJ; Lee BK; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
J Am Heart Assoc; 2020 Jun; 9(11):e016218. PubMed ID: 32419586
[TBL] [Abstract][Full Text] [Related]
11. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
Maltais S; Perrault LP; Do QB
Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention.
Dargham BB; Baskar A; Tejani I; Cui Z; Chauhan S; Sum-Ping J; Weideman RA; Banerjee S
Cardiovasc Revasc Med; 2019 Sep; 20(9):805-811. PubMed ID: 30579773
[TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
[TBL] [Abstract][Full Text] [Related]
14. Does dual antiplatelet therapy affect blood loss and transfusion requirements in robotic-assisted coronary artery surgery?
Hemli JM; Darla LS; Panetta CR; Jennings J; Subramanian VA; Patel NC
Innovations (Phila); 2012; 7(6):399-402. PubMed ID: 23422801
[TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
Charif F; Hamdan R; Youness G; El Zein A; Issa M; Jassar Y; Younes M; Saab M
J Cardiothorac Surg; 2019 Nov; 14(1):202. PubMed ID: 31775803
[TBL] [Abstract][Full Text] [Related]
16. Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding?
Gielen CL; Bruggemans EF; Stijnen T; Eikenboom J; Tavilla G; Brand A; Klautz RJ
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e64-70. PubMed ID: 26248820
[TBL] [Abstract][Full Text] [Related]
17. Platelet inhibition and bleeding complications in cardiac surgery: A review.
Hansson EC; Jeppsson A
Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
[TBL] [Abstract][Full Text] [Related]
18. Preoperative clopidogrel and outcomes in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
Qu J; Zhang D; Zhang H; Rao C; Chen S; Zhao Y; Zheng Z
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1044-1052.e15. PubMed ID: 32444184
[TBL] [Abstract][Full Text] [Related]
19. Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events.
Rodriguez A; Guilera N; Mases A; Sierra P; Oliva JC; Colilles C;
Br J Anaesth; 2018 Jan; 120(1):67-76. PubMed ID: 29397139
[TBL] [Abstract][Full Text] [Related]
20. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial.
Li Y; Jing Q; Wang B; Wang X; Li J; Qiao S; Chen S; Angiolillo DJ; Han Y
Am Heart J; 2020 Oct; 228():1-7. PubMed ID: 32739652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
